Combination Therapy Patterns and Predictors of ADHD in Commercially Insured and Medicaid Populations

References

• . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
   Google Scholar
• . Kessler RC, Adler L, Barkley R, . The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention (CDC). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children—United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep. 2010;59(44):1439–1443
   PubMedGoogle Scholar
• . Montejano L, Sasané R, Hodgkins P, Russo L, Huse D. Adult ADHD: prevalence of diagnosis in a US population with employer health insurance. Curr Med Res Opin. 2011;27( suppl 2):5–11
   PubMed Web of Science ®Google Scholar
• . Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child. 2005;90( suppl 1):i2–i7
   PubMed Web of Science ®Google Scholar
• . Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921
   PubMed Web of Science ®Google Scholar
• . Dodson WW. Pharmacotherapy of adult ADHD. J Clin Psychol. 2005;61(5):589–606
   PubMed Web of Science ®Google Scholar
• . Olfson M, Gameroff MJ, Marcus SC, Jensen PS. National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry. 2003;160(6):1071–1077
   PubMed Web of Science ®Google Scholar
• . Horst RO, Hendren RL. Integrated pharmacologic treatment of attention-deficit hyperactivity disorder (ADHD). Essent Psychopharmacol. 2005;6(5):250–261
   PubMedGoogle Scholar
• . Kimko HC, Cross JT, Abernethy DR. Pharmacokinetics and clinical effectiveness of methylphenidate. Clin Pharmacokinet. 1999;37(6):457–470
   PubMed Web of Science ®Google Scholar
• . Pohl GM, Van Brunt DL, Ye W, Stoops WW, Johnston JA. A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD). BMC Health Serv Res. 2009;9:95
   PubMed Web of Science ®Google Scholar
• . Barner JC, Khoza S, Oladapo A. ADHD medication use, adherence, persistence, and cost among Texas Medicaid children. Curr Med Res Opin. 2011;27( suppl 2):13–22
   PubMed Web of Science ®Google Scholar
• . Christensen L, Sasané R, Hodgkins P, Harley C, Tetali S. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin. 2010;26(4):977–989
   PubMed Web of Science ®Google Scholar
• . Hodgkins P, Sasané R, Meijer WM. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. Clin Ther. 2011;33(2):188–203
   PubMed Web of Science ®Google Scholar
• . Lawson KA, Johnsrud M, Hodgkins P, Sasané R, Crismon ML. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program. Clin Ther. 2012;34(4):944–956
   PubMed Web of Science ®Google Scholar
• . Wolraich M, Brown L, Brown RT, ; Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–1022
   PubMed Web of Science ®Google Scholar
• . Pliszka SR, Crismon ML, Hughes CW, ; Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45(6):642–657
   PubMed Web of Science ®Google Scholar
• . Stojanovski SD, Rasu RS, Balkrishnan R, Nahata MC. Trends in medication prescribing for pediatric sleep difficulties in US outpatient settings. Sleep. 2007;30(8):1013–1017
   PubMed Web of Science ®Google Scholar
• . Kratochvil CJ, Lake M, Pliszka SR, Walkup JT. Pharmacological management of treatment-induced insomnia in ADHD. J Am Acad Child Adolesc Psychiatry. 2005;44(5):499–501
   PubMed Web of Science ®Google Scholar
• . Tourette's Syndrome Study Group. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002;58(4):527–536
   PubMed Web of Science ®Google Scholar
• . Hazell PL, Stuart JE. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adolesc Psychiatry. 2003;42(8):886–894
   PubMed Web of Science ®Google Scholar
• . Palumbo DR, Sallee FR, Pelham WE Jr, Bukstein OG, Daviss WB, McDermott MP. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry. 2008;47(2):180–188
   PubMed Web of Science ®Google Scholar
• . Kent JD, Blader JC, Koplewicz HS, Abikoff H, Foley CA. Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder. Pediatrics. 1995;96(2 pt 1): 320–325
   PubMed Web of Science ®Google Scholar
• . Larson K, Russ SA, Kahn RS, Halfron N. Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics. 2011;127(3):462–470
   PubMed Web of Science ®Google Scholar
• . Pringsheim T, Doja A, Gorman D, . Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy. Can J Psychiatry. 2012;57(3):133–143
   PubMed Web of Science ®Google Scholar
• . Bagheri MM, Kerbeshian J, Burd L. Recognition and management of Tourette's syndrome and tic disorders. Am Fam Physician. 1999; 59(8):2263–2272
   PubMed Web of Science ®Google Scholar
• . Coffey B, Berlin C, Naarden A. Medications and Tourette's Disorder: Combined Pharmacotherapy and Drug Interactions. National Tourette Syndrome Association. http://www.tsa-usa.org/aMedical/images/medications_and_tourettes_berlin.pdf. Accessed August 6, 2012
   Google Scholar
• . Bloch MH, Panza KE, Landeros–Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 2009;48(9):884–893
   PubMed Web of Science ®Google Scholar